文献
J-GLOBAL ID:202002210869607023
整理番号:20A2762099
メラトニンはiNOS/hTERTシグナル伝達および癌幹細胞形質を阻害することにより黒色腫治療においてBRAF標的剤ベムラフェニブを相乗作用する【JST・京大機械翻訳】
Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
著者 (26件):
Hao Jiaojiao
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Fan Wenhua
(State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, China)
,
Li Yizhuo
(State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, China)
,
Tang Ranran
(Nanjing Maternity and Child Health Care Hospital, Women’s Hospital of Nanjing Medical University, Nanjing, China)
,
Tian Chunfang
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Yang Qian
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Zhu Tianhua
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Diao Chaoliang
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Hu Sheng
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Chen Manyu
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Guo Ping
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Long Qian
(State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, China)
,
Zhang Changlin
(State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, China)
,
Qin Ge
(State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, China)
,
Yu Wendan
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Chen Miao
(State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, China)
,
Li Liren
(State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, China)
,
Qin Lijun
(Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China)
,
Wang Jingshu
(Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China)
,
Zhang Xiuping
(Cloud Health Genomics Ltd, Shanghai, China)
,
Ren Yandong
(Cloud Health Genomics Ltd, Shanghai, China)
,
Zhou Penghui
(State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, China)
,
Zou Lijuan
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Jiang Kui
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Guo Wei
(Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical University, Dalian, China)
,
Deng Wuguo
(State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, China)
資料名:
Journal of Experimental & Clinical Cancer Research (Web)
(Journal of Experimental & Clinical Cancer Research (Web))
巻:
38
号:
1
ページ:
1-15
発行年:
2019年
JST資料番号:
U7514A
ISSN:
1756-9966
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)